Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Halasi, Marianna ^a,b   Gartel, Andrei L ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN FOXM1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEASOME; PROTEINASE INHIBITOR; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; CELL DEATH; DOWN REGULATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; METABOLISM; RADIATION RESPONSE; STEM CELL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE 4; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; RNA, SMALL INTERFERING; STEM CELLS;

EID: 84857675676     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031761     Document Type: Article

References (46)

1. Burdak-Rothkamm S, Prise KM, (2009) New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells. Eur J Pharmacol 625: 151-155.
2. Tan Y, Raychaudhuri P, Costa RH, (2007) Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol 27: 1007-1016.
3. Barsotti AM, Prives C, (2009) Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene 28: 4295-4305.
4. Pandit B, Halasi M, Gartel AL, (2009) p53 negatively regulates expression of FoxM1. Cell Cycle 8: 3425-3427.
5. Korver W, Roose J, Clevers H, (1997) The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res 25: 1715-1719.
6. Ye H, Kelly TF, Samadani U, Lim L, Rubio S, et al. (1997) Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol 17: 1626-1641.
7. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, et al. (2005) Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 25: 10875-10894.
8. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grutzmann R, (2004) Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6: 744-750.
9. Laoukili J, Stahl M, Medema RH, (2006) FoxM1: At the crossroads of ageing and cancer. Biochim Biophys Acta In Press.
10. Wierstra I, Alves J, (2007) FOXM1, a typical proliferation-associated transcription factor. Biol Chem 388: 1257-1274.
11. Kwok JM, Peck B, Monteiro LJ, Schwenen HD, Millour J, et al. (2010) FOXM1 confers acquired cisplatin resistance in breast cancer cells. Mol Cancer Res 8: 24-34.
12. Gartel AL, (2008) FoxM1 inhibitors as potential anticancer drugs. Expert Opin Ther Targets 12: 663-665.
13. Radhakrishnan SK, Gartel AL, (2008) FOXM1: the Achilles' heel of cancer? Nat Rev Cancer 8: c1; author reply c2.
14. Chetty C, Bhoopathi P, Rao JS, Lakka SS, (2009) Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer 124: 2468-2477.
15. Alvarez-Fernandez M, Halim VA, Krenning L, Aprelia M, Mohammed S, et al. (2010) Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1. EMBO Rep 11: 452-458.
16. Dai B, Kang SH, Gong W, Liu M, Aldape KD, et al. (2007) Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 26: 6212-6219.
17. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH, (2007) Down-regulation of Forkhead Box M1 Transcription Factor Leads to the Inhibition of Invasion and Angiogenesis of Pancreatic Cancer Cells. Cancer Res 67: 8293-8300.
18. Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, et al. (2008) FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem 283: 20770-20778.
19. Chen CH, Chien CY, Huang CC, Hwang CF, Chuang HC, et al. (2009) Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene 28: 2723-2737.
20. Ahmad A, Wang Z, Kong D, Ali S, Li Y, et al. (2010) FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res Treat 122: 337-346.
21. Behren A, Muhlen S, Acuna Sanhueza GA, Schwager C, Plinkert PK, et al. (2010) Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion. Oncogene 29: 1519-1530.
22. Wu QF, Liu C, Tai MH, Liu D, Lei L, et al. (2010) Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro. Acta Pharmacol Sin 31: 361-366.
23. Park HJ, Gusarova G, Wang Z, Carr JR, Li J, et al. (2011) Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med 3: 21-34.
24. Li Y, Ligr M, McCarron JP, Daniels G, Zhang D, et al. (2011) Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and-independent prostate cancer growth and invasion. Clin Cancer Res 17: 4414-4424.
25. Radhakrishnan SK, Bhat UG, Hughes DE, Wang IC, Costa RH, et al. (2006) Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1. Cancer Res 66: 9731-9735.
26. Bhat UG, Zipfel PA, Tyler DS, Gartel AL, (2008) Novel anticancer compounds induce apoptosis in melanoma cells. Cell Cycle 7: 1851-1855.
27. Bhat UG, Halasi M, Gartel AL, (2009) Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PLoS ONE 4: e5592.
28. Halasi M, Zhao H, Dahari H, Bhat UG, Gonzalez EB, et al. (2010) Thiazole antibiotics against breast cancer. Cell Cycle 9.
29. Bhat UG, Halasi M, Gartel AL, (2009) FoxM1 is a general target for proteasome inhibitors. PLoS One 4: e6593.
30. Carr JR, Park HJ, Wang Z, Kiefer MM, Raychaudhuri P, (2010) FoxM1 mediates resistance to herceptin and paclitaxel. Cancer Res 70: 5054-5063.
31. Ip YT, Davis RJ, (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10: 205-219.
32. Davis RJ, (2000) Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252.
33. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH, (1996) The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 271: 31929-31936.
34. Ventura JJ, Hubner A, Zhang C, Flavell RA, Shokat KM, et al. (2006) Chemical genetic analysis of the time course of signal transduction by JNK. Mol Cell 21: 701-710.
35. Cory S, Huang DC, Adams JM, (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607.
36. Zhou F, Yang Y, Xing D, (2011) Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. Febs J 278: 403-413.
37. Llambi F, Green DR, (2011) Apoptosis and oncogenesis: give and take in the BCL-2 family. Curr Opin Genet Dev 21: 12-20.
38. Radhakrishnan SK, Gierut J, Gartel AL, (2006) Multiple alternate p21 transcripts are regulated by p53 in human cells. Oncogene 25: 1812-1815.
39. Levine AJ, (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
40. Teh MT, Gemenetzidis E, Chaplin T, Young BD, Philpott MP, (2010) Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes. Mol Cancer 9: 45.
41. Wang M, Gartel AL, (2011) Micelle-Encapsulated Thiostrepton as an Effective Nanomedicine for Inhibiting Tumor Growth and for Suppressing FOXM1 in Human Xenografts. Mol Cancer Ther 10: 2287-2297.
42. Su ZZ, Lebedeva IV, Sarkar D, Emdad L, Gupta P, et al. (2006) Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene 25: 2339-2348.
43. Kim MJ, Choi SY, Park IC, Hwang SG, Kim C, et al. (2008) Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells. Mol Cancer Res 6: 1718-1731.
44. Kim CH, Won M, Choi CH, Ahn J, Kim BK, et al. (2010) Increase of RhoB in gamma-radiation-induced apoptosis is regulated by c-Jun N-terminal kinase in Jurkat T cells. Biochem Biophys Res Commun 391: 1182-1186.
45. Major ML, Lepe R, Costa RH, (2004) Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Mol Cell Biol 24: 2649-2661.
46. Stevenson HS, Fu SW, Pinzone JJ, Rheey J, Simmens SJ, et al. (2007) BP1 transcriptionally activates bcl-2 and inhibits TNFalpha-induced cell death in MCF7 breast cancer cells. Breast Cancer Res 9: R60.